The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Angioedema (may cause UAO, asphyxia and death)
Publications
A Rare Case of Valsartan-Induced Angioedema.
Cureus 2025 Jun;17;e85623 — 2025 Jun — e85623
Intraoperative angioedema induced by angiotensin II receptor blocker: a case report.
Patient safety in surgery 2018;12;27 — 2018 — 27
Angiotensin-converting Enzyme Inhibitor Angioedema Requiring Admission to an Intensive Care Unit.
The American journal of medicine 2015 Jul;128;785-9 — 2015 Jul — 785-9
Side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: are we facing a new syndrome.
The American journal of cardiology 2012 Nov 15;110;1552-3 — 2012 Nov 15 — 1552-3
Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis.
American journal of otolaryngology 2011 Nov-Dec;32;624-6 — 2011 Nov-Dec — 624-6
Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.
American journal of therapeutics 2012 Nov;19;e189-92 — 2012 Nov — e189-92
[Regarding: Shuster C, Reinhart WH, Hartmann K, Kuhn M. Angioma induced by ACE inhibitors and angiotensin II receptor antagonists: analysis of 98 cases].
Schweizerische medizinische Wochenschrift 1999 Jul 03;129;1003-4 — 1999 Jul 03 — 1003-4
[Angioedema induced by ACE inhibitors and angiotensin II-receptor antagonists: analysis of 98 cases].
Schweizerische medizinische Wochenschrift 1999 Mar 06;129;362-9 — 1999 Mar 06 — 362-9